( August 6, 2026, 12:28 PM EDT) -- HOUSTON — A nationwide pharmacy that dispenses compounded tirzepatide XE "tirzepatide" products failed to convince a Texas federal judge that compounded pharmaceuticals are not “new drugs” under the state laws at issue in an unfair competition suit filed by Eli Lilly and Co.; the judge denied Revive RX LLC’s motion for judgment on the pleadings....